Nanjing Leads Biolabs Co. Ltd. Announces Date for Extraordinary General Meeting

Reuters11-28
Nanjing Leads Biolabs Co. Ltd. Announces Date for Extraordinary General Meeting

Nanjing Leads Biolabs Co. Ltd. will hold an extraordinary general meeting on December 17, 2025, in Nanjing, the People's Republic of China. During the meeting, shareholders will consider and vote on several special resolutions, including the proposed adoption of the H Share Award Scheme and the proposed authorization to the Board and/or the Delegatee to handle matters related to the H Share Award Scheme.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanjing Leads Biolabs Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251128-11933499), on November 28, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment